| Year |
Citation |
Score |
| 2020 |
Cory S, Nguyen HV, Vandenberg CJ, Ng AP, Anstee NS, Rimes J, Hawkins E, Robati MR. Development and Survival of MYC-driven Lymphomas Requires MYC-Antagonist MNT to Curb MYC-induced Apoptosis. Blood. PMID 31978211 DOI: 10.1182/Blood.2019003014 |
0.423 |
|
| 2018 |
Anstee NS, Bilardi RA, Ng AP, Xu Z, Robati M, Vandenberg CJ, Cory S. Impact of elevated anti-apoptotic MCL-1 and BCL-2 on the development and treatment of MLL-AF9 AML in mice. Cell Death and Differentiation. PMID 30470795 DOI: 10.1038/S41418-018-0209-1 |
0.358 |
|
| 2018 |
Cory S. Phosphatidylserine hide-and-seek. Proceedings of the National Academy of Sciences of the United States of America. PMID 30446613 DOI: 10.1073/Pnas.1817485115 |
0.339 |
|
| 2018 |
Tuzlak S, Haschka MD, Mokina AM, Rülicke T, Cory S, Labi V, Villunger A. Differential effects of Vav-promoter-driven overexpression of BCLX and BFL1 on lymphocyte survival and B cell lymphomagenesis. The Febs Journal. 285: 1403-1418. PMID 29498802 DOI: 10.1111/Febs.14426 |
0.398 |
|
| 2018 |
Mensink M, Anstee NS, Robati M, Schenk RL, Herold MJ, Cory S, Vandenberg CJ. Anti-apoptotic A1 is not essential for lymphoma development in Eµ-Myc mice but helps sustain transplanted Eµ-Myc tumour cells. Cell Death and Differentiation. PMID 29339775 DOI: 10.1038/S41418-017-0045-8 |
0.391 |
|
| 2017 |
Adams JM, Cory S. The BCL-2 arbiters of apoptosis and their growing role as cancer targets. Cell Death and Differentiation. PMID 29099483 DOI: 10.1038/Cdd.2017.161 |
0.551 |
|
| 2017 |
Campbell KJ, Vandenberg CJ, Anstee NS, Hurlin PJ, Cory S. Mnt modulates Myc-driven lymphomagenesis. Cell Death and Differentiation. PMID 28800127 DOI: 10.1038/Cdd.2017.131 |
0.411 |
|
| 2017 |
Carrington EM, Zhan Y, Brady JL, Zhang JG, Sutherland RM, Anstee NS, Schenk RL, Vikstrom IB, Delconte RB, Segal D, Huntington ND, Bouillet P, Tarlinton DM, Huang DC, Strasser A, ... Cory S, et al. Anti-apoptotic proteins BCL-2, MCL-1 and A1 summate collectively to maintain survival of immune cell populations both in vitro and in vivo. Cell Death and Differentiation. PMID 28362427 DOI: 10.1038/Cdd.2017.30 |
0.381 |
|
| 2016 |
Cory S, Roberts AW, Colman PM, Adams JM. Targeting BCL-2-like Proteins to Kill Cancer Cells. Trends in Cancer. 2: 443-460. PMID 28741496 DOI: 10.1016/J.Trecan.2016.07.001 |
0.562 |
|
| 2016 |
Anstee NS, Vandenberg CJ, Campbell KJ, Hughes PD, O'Reilly LA, Cory S. Overexpression of Mcl-1 exacerbates lymphocyte accumulation and autoimmune kidney disease in lpr mice. Cell Death and Differentiation. PMID 27813531 DOI: 10.1038/Cdd.2016.125 |
0.413 |
|
| 2016 |
Bilardi RA, Anstee NS, Glaser SP, Robati M, Vandenberg CJ, Cory S. Impact of loss of BH3-only proteins on the development and treatment of MLL-fusion gene-driven AML in mice. Cell Death & Disease. 7: e2351. PMID 27584789 DOI: 10.1038/Cddis.2016.258 |
0.357 |
|
| 2016 |
Vandenberg CJ, Motoyama N, Cory S. FoxO3 suppresses Myc-driven lymphomagenesis Cell Death and Disease. 7. PMID 26764572 DOI: 10.1038/Cddis.2015.396 |
0.374 |
|
| 2015 |
Cory S. Masterminding B Cells. Journal of Immunology (Baltimore, Md. : 1950). 195: 763-5. PMID 26188069 DOI: 10.4049/Jimmunol.1501277 |
0.335 |
|
| 2015 |
Adams JM, Cory S. Donald Metcalf: The father of modern hematology. Proceedings of the National Academy of Sciences of the United States of America. 112: 2628-9. PMID 25646425 DOI: 10.1073/Pnas.1500346112 |
0.508 |
|
| 2015 |
Vandenberg C, Cory S, Bilardi R, Anstee N, Bouillet P, Strasser A. Abstract IA31: Harnessing death for life. Clinical Cancer Research. 21. DOI: 10.1158/1557-3265.Hemmal14-Ia31 |
0.396 |
|
| 2014 |
Vandenberg CJ, Waring P, Strasser A, Cory S. Plasmacytomagenesis in Eμ-v-abl transgenic mice is accelerated when apoptosis is restrained. Blood. 124: 1099-109. PMID 24986687 DOI: 10.1182/Blood-2014-04-570770 |
0.409 |
|
| 2014 |
Vandenberg CJ, Josefsson EC, Campbell KJ, James C, Lawlor KE, Kile BT, Cory S. Loss of Bak enhances lymphocytosis but does not ameliorate thrombocytopaenia in BCL-2 transgenic mice. Cell Death and Differentiation. 21: 676-84. PMID 24464220 DOI: 10.1038/Cdd.2013.201 |
0.34 |
|
| 2013 |
Vandenberg CJ, Cory S. ABT-199, a new Bcl-2-specific BH3 mimetic, has in vivo efficacy against aggressive Myc-driven mouse lymphomas without provoking thrombocytopenia. Blood. 121: 2285-8. PMID 23341542 DOI: 10.1182/Blood-2013-01-475855 |
0.379 |
|
| 2012 |
Campbell KJ, Gray DH, Anstee N, Strasser A, Cory S. Elevated Mcl-1 inhibits thymocyte apoptosis and alters thymic selection. Cell Death and Differentiation. 19: 1962-71. PMID 22743995 DOI: 10.1038/Cdd.2012.84 |
0.407 |
|
| 2012 |
Mérino D, Khaw SL, Glaser SP, Anderson DJ, Belmont LD, Wong C, Yue P, Robati M, Phipson B, Fairlie WD, Lee EF, Campbell KJ, Vandenberg CJ, Cory S, Roberts AW, et al. Bcl-2, Bcl-x(L), and Bcl-w are not equivalent targets of ABT-737 and navitoclax (ABT-263) in lymphoid and leukemic cells. Blood. 119: 5807-16. PMID 22538851 DOI: 10.1182/Blood-2011-12-400929 |
0.343 |
|
| 2012 |
Happo L, Strasser A, Cory S. BH3-only proteins in apoptosis at a glance. Journal of Cell Science. 125: 1081-7. PMID 22492984 DOI: 10.1242/Jcs.090514 |
0.354 |
|
| 2011 |
Strasser A, Cory S, Adams JM. Deciphering the rules of programmed cell death to improve therapy of cancer and other diseases. The Embo Journal. 30: 3667-83. PMID 21863020 DOI: 10.1038/Emboj.2011.307 |
0.573 |
|
| 2011 |
Croker BA, O'Donnell JA, Nowell CJ, Metcalf D, Dewson G, Campbell KJ, Rogers KL, Hu Y, Smyth GK, Zhang JG, White M, Lackovic K, Cengia LH, O'Reilly LA, Bouillet P, ... Cory S, et al. Fas-mediated neutrophil apoptosis is accelerated by Bid, Bak, and Bax and inhibited by Bcl-2 and Mcl-1. Proceedings of the National Academy of Sciences of the United States of America. 108: 13135-40. PMID 21768356 DOI: 10.1073/Pnas.1110358108 |
0.382 |
|
| 2010 |
Happo L, Cragg MS, Phipson B, Haga JM, Jansen ES, Herold MJ, Dewson G, Michalak EM, Vandenberg CJ, Smyth GK, Strasser A, Cory S, Scott CL. Maximal killing of lymphoma cells by DNA damage-inducing therapy requires not only the p53 targets Puma and Noxa, but also Bim. Blood. 116: 5256-67. PMID 20829369 DOI: 10.1182/Blood-2010-04-280818 |
0.355 |
|
| 2010 |
Campbell KJ, Bath ML, Turner ML, Vandenberg CJ, Bouillet P, Metcalf D, Scott CL, Cory S. Elevated Mcl-1 perturbs lymphopoiesis, promotes transformation of hematopoietic stem/progenitor cells, and enhances drug resistance. Blood. 116: 3197-207. PMID 20631380 DOI: 10.1182/Blood-2010-04-281071 |
0.364 |
|
| 2010 |
Strasser A, Bouillet P, Adams JM, Kelly PN, Kelly G, Herold M, Glaser S, Robb L, O'Reilly LA, Delbridge A, Grabow S, Scott CL, Cory S. The many roles of apoptotic cell death in the immune system (LL3-6) Chairperson: Shin Yonehara International Immunology. 22. DOI: 10.1093/Intimm/Dxq207 |
0.54 |
|
| 2008 |
Mason KD, Vandenberg CJ, Scott CL, Wei AH, Cory S, Huang DC, Roberts AW. In vivo efficacy of the Bcl-2 antagonist ABT-737 against aggressive Myc-driven lymphomas. Proceedings of the National Academy of Sciences of the United States of America. 105: 17961-6. PMID 19004807 DOI: 10.1073/Pnas.0809957105 |
0.39 |
|
| 2007 |
Adams JM, Cory S. Bcl-2-regulated apoptosis: mechanism and therapeutic potential. Current Opinion in Immunology. 19: 488-96. PMID 17629468 DOI: 10.1016/J.Coi.2007.05.004 |
0.586 |
|
| 2007 |
Adams JM, Cory S. The Bcl-2 apoptotic switch in cancer development and therapy. Oncogene. 26: 1324-37. PMID 17322918 DOI: 10.1038/Sj.Onc.1210220 |
0.572 |
|
| 2006 |
van Delft MF, Wei AH, Mason KD, Vandenberg CJ, Chen L, Czabotar PE, Willis SN, Scott CL, Day CL, Cory S, Adams JM, Roberts AW, Huang DC. The BH3 mimetic ABT-737 targets selective Bcl-2 proteins and efficiently induces apoptosis via Bak/Bax if Mcl-1 is neutralized. Cancer Cell. 10: 389-99. PMID 17097561 DOI: 10.1016/J.Ccr.2006.08.027 |
0.585 |
|
| 2006 |
Smith DP, Bath ML, Metcalf D, Harris AW, Cory S. MYC levels govern hematopoietic tumor type and latency in transgenic mice. Blood. 108: 653-61. PMID 16537801 DOI: 10.1182/Blood-2006-01-0172 |
0.383 |
|
| 2006 |
Mason KD, Vandenberg CJ, Delft MFv, Wei AH, Cory S, Clare SL, Roberts AW, Huang DCS. The BH3 Mimetic, ABT-737, Is Effective Against Bcl-2 Overexpressing Lymphoid Tumors. Blood. 108: 826-826. DOI: 10.1182/Blood.V108.11.826.826 |
0.352 |
|
| 2005 |
Adams JM, Huang DC, Strasser A, Willis S, Chen L, Wei A, van Delft M, Fletcher JI, Puthalakath H, Kuroda J, Michalak EM, Kelly PN, Bouillet P, Villunger A, O'Reilly L, ... ... Cory S, et al. Subversion of the Bcl-2 life/death switch in cancer development and therapy. Cold Spring Harbor Symposia On Quantitative Biology. 70: 469-77. PMID 16869785 DOI: 10.1101/Sqb.2005.70.009 |
0.581 |
|
| 2005 |
Cory S, Adams JM. Killing cancer cells by flipping the Bcl-2/Bax switch. Cancer Cell. 8: 5-6. PMID 16023593 DOI: 10.1016/J.Ccr.2005.06.012 |
0.56 |
|
| 2005 |
Smith DP, Bath ML, Harris AW, Cory S. T-cell lymphomas mask slower developing B-lymphoid and myeloid tumours in transgenic mice with broad haemopoietic expression of MYC. Oncogene. 24: 3544-53. PMID 15688022 DOI: 10.1038/Sj.Onc.1208399 |
0.37 |
|
| 2004 |
Egle A, Harris AW, Bouillet P, Cory S. Bim is a suppressor of Myc-induced mouse B cell leukemia. Proceedings of the National Academy of Sciences of the United States of America. 101: 6164-9. PMID 15079075 DOI: 10.1073/Pnas.0401471101 |
0.419 |
|
| 2004 |
Egle A, Harris AW, Bath ML, O'Reilly L, Cory S. VavP-Bcl2 transgenic mice develop follicular lymphoma preceded by germinal center hyperplasia. Blood. 103: 2276-83. PMID 14630790 DOI: 10.1182/Blood-2003-07-2469 |
0.41 |
|
| 2003 |
Cory S, Huang DC, Adams JM. The Bcl-2 family: roles in cell survival and oncogenesis. Oncogene. 22: 8590-607. PMID 14634621 DOI: 10.1038/Sj.Onc.1207102 |
0.584 |
|
| 2002 |
Adams JM, Cory S. Apoptosomes: engines for caspase activation. Current Opinion in Cell Biology. 14: 715-20. PMID 12473344 DOI: 10.1016/S0955-0674(02)00381-2 |
0.571 |
|
| 2002 |
Cory S, Adams JM. The Bcl2 family: regulators of the cellular life-or-death switch. Nature Reviews. Cancer. 2: 647-56. PMID 12209154 DOI: 10.1038/Nrc883 |
0.57 |
|
| 2002 |
Bouillet P, Purton JF, Godfrey DI, Zhang LC, Coultas L, Puthalakath H, Pellegrini M, Cory S, Adams JM, Strasser A. BH3-only Bcl-2 family member Bim is required for apoptosis of autoreactive thymocytes. Nature. 415: 922-6. PMID 11859372 DOI: 10.1038/415922A |
0.605 |
|
| 2002 |
Bouillet P, Purton JF, Godfrey DI, Zhang L, Coultas L, Puthalakath H, Pellegrini M, Cory S, Adams JM, Strasser A. corrigenda: BH3-only Bcl-2 family member Bim is required for apoptosis of autoreactive thymocytes Nature. 418: 108-108. DOI: 10.1038/Nature00885 |
0.505 |
|
| 2001 |
Bouillet P, Cory S, Zhang LC, Strasser A, Adams JM. Degenerative disorders caused by Bcl-2 deficiency prevented by loss of its BH3-only antagonist Bim. Developmental Cell. 1: 645-53. PMID 11709185 DOI: 10.1016/S1534-5807(01)00083-1 |
0.578 |
|
| 2001 |
O'Reilly LA, Print C, Hausmann G, Moriishi K, Cory S, Huang DCS, Strasser A. Tissue expression and subcellular localization of the pro-survival molecule Bcl-w. Cell Death & Differentiation. 8: 486-494. PMID 11423909 DOI: 10.1038/Sj.Cdd.4400835 |
0.421 |
|
| 2001 |
Adams JM, Cory S. Life-or-death decisions by the Bcl-2 protein family. Trends in Biochemical Sciences. 26: 61-6. PMID 11165519 DOI: 10.1016/S0968-0004(00)01740-0 |
0.57 |
|
| 2000 |
Strasser A, Puthalakath H, Bouillet P, Huang DC, O'Connor L, O'Reilly LA, Cullen L, Cory S, Adams JM. The role of bim, a proapoptotic BH3-only member of the Bcl-2 family in cell-death control. Annals of the New York Academy of Sciences. 917: 541-8. PMID 11268382 DOI: 10.1111/J.1749-6632.2000.Tb05419.X |
0.613 |
|
| 2000 |
Bouillet P, Huang DC, O'Reilly LA, Puthalakath H, O'Connor L, Cory S, Adams JM, Strasser A. The role of the pro-apoptotic Bcl-2 family member bim in physiological cell death. Annals of the New York Academy of Sciences. 926: 83-9. PMID 11193044 DOI: 10.1111/J.1749-6632.2000.Tb05601.X |
0.596 |
|
| 2000 |
Cory S, Huang DCS, Print CG, Moriishi K, Bouillet P, O'reilly LA, Puthalakath H, Ogilvy S, O'connor L, Bath ML, Hausmann G, Metcalf D, Harris AW, Adams JM. The Bcl-2 Family: Arbiters of Life and Death Biochemical Society Transactions. 28. DOI: 10.1042/Bst028A098C |
0.527 |
|
| 1999 |
Adams JM, Huang DC, Puthalakath H, Bouillet P, Vairo G, Moriishi K, Hausmann G, O'Reilly L, Newton K, Ogilvy S, Bath ML, Print CG, Harris AW, Strasser A, Cory S. Control of apoptosis in hematopoietic cells by the Bcl-2 family of proteins. Cold Spring Harbor Symposia On Quantitative Biology. 64: 351-8. PMID 11232307 DOI: 10.1101/Sqb.1999.64.351 |
0.572 |
|
| 1999 |
Cory S. Wavering on commitment Nature. 401: 538-539. PMID 10524616 DOI: 10.1038/44035 |
0.309 |
|
| 1999 |
Adams JM, Harris AW, Strasser A, Ogilvy S, Cory S. Transgenic models of lymphoid neoplasia and development of a pan-hematopoietic vector. Oncogene. 18: 5268-77. PMID 10498879 DOI: 10.1038/Sj.Onc.1202997 |
0.593 |
|
| 1999 |
Moriishi K, Huang DC, Cory S, Adams JM. Bcl-2 family members do not inhibit apoptosis by binding the caspase activator Apaf-1. Proceedings of the National Academy of Sciences of the United States of America. 96: 9683-8. PMID 10449754 DOI: 10.1073/Pnas.96.17.9683 |
0.572 |
|
| 1999 |
Holmgreen SP, Huang DC, Adams JM, Cory S. Survival activity of Bcl-2 homologs Bcl-w and A1 only partially correlates with their ability to bind pro-apoptotic family members. Cell Death and Differentiation. 6: 525-32. PMID 10381646 DOI: 10.1038/Sj.Cdd.4400519 |
0.576 |
|
| 1999 |
Innes KM, Szilvassy SJ, Davidson HE, Gibson L, Adams JM, Cory S. Retroviral transduction of enriched hematopoietic stem cells allows lifelong Bcl-2 expression in multiple lineages but does not perturb hematopoiesis. Experimental Hematology. 27: 75-87. PMID 9923446 DOI: 10.1016/S0301-472X(98)00015-0 |
0.575 |
|
| 1998 |
Print CG, Loveland KL, Gibson L, Meehan T, Stylianou A, Wreford N, de Kretser D, Metcalf D, Köntgen F, Adams JM, Cory S. Apoptosis regulator bcl-w is essential for spermatogenesis but appears otherwise redundant. Proceedings of the National Academy of Sciences of the United States of America. 95: 12424-31. PMID 9770502 DOI: 10.1073/Pnas.95.21.12424 |
0.598 |
|
| 1998 |
Cory S. Cell death throes Proceedings of the National Academy of Sciences of the United States of America. 95: 12077-12079. PMID 9770441 DOI: 10.1073/Pnas.95.21.12077 |
0.329 |
|
| 1998 |
Adams JM, Cory S. The Bcl-2 protein family: arbiters of cell survival. Science (New York, N.Y.). 281: 1322-6. PMID 9735050 DOI: 10.1126/Science.281.5381.1322 |
0.596 |
|
| 1998 |
Cory S, Adams JM. Matters of life and death: programmed cell death at Cold Spring Harbor. Biochimica Et Biophysica Acta. 1377: R25-44. PMID 9606979 DOI: 10.1016/S0304-419X(98)00003-1 |
0.525 |
|
| 1998 |
Huang DC, Adams JM, Cory S. The conserved N-terminal BH4 domain of Bcl-2 homologues is essential for inhibition of apoptosis and interaction with CED-4. The Embo Journal. 17: 1029-39. PMID 9463381 DOI: 10.1093/Emboj/17.4.1029 |
0.584 |
|
| 1998 |
O'Connor L, Strasser A, O'Reilly LA, Hausmann G, Adams JM, Cory S, Huang DC. Bim: a novel member of the Bcl-2 family that promotes apoptosis. The Embo Journal. 17: 384-95. PMID 9430630 DOI: 10.1093/Emboj/17.2.384 |
0.592 |
|
| 1997 |
Harris AW, Strasser A, Bath ML, Elefanty AG, Cory S. Lymphomas and Plasmacytomas in Transgenic Mice Involving Bcl2, Myc and v-Abl Current Topics in Microbiology and Immunology. 224: 221-230. PMID 9308245 DOI: 10.1007/978-3-642-60801-8_22 |
0.367 |
|
| 1997 |
Huang DCS, O'Reilly LA, Strasser A, Cory S. The anti-apoptosis function of Bcl-2 can be genetically separated from its inhibitory effect on cell cycle entry The Embo Journal. 16: 4628-4638. PMID 9303307 DOI: 10.1093/Emboj/16.15.4628 |
0.39 |
|
| 1997 |
Huang DC, Cory S, Strasser A. Bcl-2, Bcl-XL and adenovirus protein E1B19kD are functionally equivalent in their ability to inhibit cell death. Oncogene. 14: 405-414. PMID 9053837 DOI: 10.1038/Sj.Onc.1200848 |
0.346 |
|
| 1996 |
Strasser A, Elefanty AG, Harris AW, Cory S. Progenitor tumours from Emu‐bcl‐2‐myc transgenic mice have lymphomyeloid differentiation potential and reveal developmental differences in cell survival. The Embo Journal. 15: 3823-3834. DOI: 10.1002/J.1460-2075.1996.Tb00756.X |
0.395 |
|
| 1995 |
Cory S. Regulation of Lymphocyte Survival by the BCL-2 Gene Family Annual Review of Immunology. 13: 513-543. PMID 7612233 DOI: 10.1146/Annurev.Iy.13.040195.002501 |
0.451 |
|
| 1995 |
Strasser A, Harris AW, Huang DCS, Krammer PH, Cory S. Bcl‐2 and Fas/APO‐1 regulate distinct pathways to lymphocyte apoptosis. The Embo Journal. 14: 6136-6147. DOI: 10.1002/J.1460-2075.1995.Tb00304.X |
0.41 |
|
| 1994 |
Strasser A, Harris AW, Corcoran LM, Cory S. Bcl-2 expression promotes B- but not T-lymphoid development in scid mice. Nature. 368: 457-460. PMID 8133891 DOI: 10.1038/368457A0 |
0.408 |
|
| 1994 |
Strasser A, Harris AW, Boehmer Hv, Cory S. Positive and negative selection of T cells in T-cell receptor transgenic mice expressing a bcl-2 transgene. Proceedings of the National Academy of Sciences of the United States of America. 91: 1376-1380. PMID 8108419 DOI: 10.1073/Pnas.91.4.1376 |
0.371 |
|
| 1994 |
Strasser A, Harris AW, Jacks T, Cory S. DNA damage can induce apoptosis in proliferating lymphoid cells via p53-independent mechanisms inhibitable by Bcl-2. Cell. 79: 329-39. PMID 7954799 DOI: 10.1016/0092-8674(94)90201-1 |
0.363 |
|
| 1994 |
Lindeman GJ, Adams JM, Cory S, Harris AW. B-lymphoid to granulocytic switch during hematopoiesis in a transgenic mouse strain. Immunity. 1: 517-27. PMID 7895160 DOI: 10.1016/1074-7613(94)90094-9 |
0.582 |
|
| 1994 |
Cory S, Harris AW, Strasser A. Insights from Transgenic Mice regarding the Role of bcl-2 in Normal and Neoplastic Lymphoid Cells Philosophical Transactions of the Royal Society B. 345: 289-295. PMID 7846127 DOI: 10.1098/Rstb.1994.0108 |
0.43 |
|
| 1994 |
Cory S, Strasser A, Jacks T, Corcoran LM, Metz T, Harris AW, Adams JM. Enhanced cell survival and tumorigenesis. Cold Spring Harbor Symposia On Quantitative Biology. 59: 365-75. PMID 7587089 DOI: 10.1101/Sqb.1994.059.01.041 |
0.536 |
|
| 1994 |
Szilvassy S, Cory S. Efficient retroviral gene transfer to purified long-term repopulating hematopoietic stem cells. Blood. 84: 74-83. DOI: 10.1182/Blood.V84.1.74.Bloodjournal84174 |
0.301 |
|
| 1993 |
Hartley SB, Cooke MP, Fulcher DA, Harris AW, Cory S, Basten A, Goodnow CC. Elimination of self-reactive B lymphocytes proceeds in two stages: arrested development and cell death. Cell. 72: 325-35. PMID 8431943 DOI: 10.1016/0092-8674(93)90111-3 |
0.357 |
|
| 1993 |
Szilvassy S, Cory S. Phenotypic and functional characterization of competitive long-term repopulating hematopoietic stem cells enriched from 5-fluorouracil- treated murine marrow Blood. 81: 2310-2320. DOI: 10.1182/Blood.V81.9.2310.Bloodjournal8192310 |
0.331 |
|
| 1993 |
Perkins AC, Cory S. Conditional immortalization of mouse myelomonocytic, megakaryocytic and mast cell progenitors by the Hox-2.4 homeobox gene. The Embo Journal. 12: 3835-3846. DOI: 10.1002/J.1460-2075.1993.Tb06062.X |
0.328 |
|
| 1992 |
Strasser A, Harris AW, Cory S. The Role of bcl -2 in Lymphoid Differentiation and Neoplastic Transformation Current Topics in Microbiology and Immunology. 182: 299-302. PMID 1490367 DOI: 10.1007/978-3-642-77633-5_37 |
0.42 |
|
| 1992 |
Elefanty AG, Cory S. Hematologic disease induced in BALB/c mice by a bcr-abl retrovirus is influenced by the infection conditions. Molecular and Cellular Biology. 12: 1755-1763. PMID 1312670 DOI: 10.1128/Mcb.12.4.1755 |
0.333 |
|
| 1992 |
Elefanty A, Cory S. bcr-abl-Induced cell lines can switch from mast cell to erythroid or myeloid differentiation in vitro. Blood. 79: 1271-1281. DOI: 10.1182/Blood.V79.5.1271.Bloodjournal7951271 |
0.359 |
|
| 1992 |
Cory S, Perkins A, Strasser A, Harris AW, Adams JM. Decreased cell death and increased self-renewal: two facets of hematopoietic cell transformation Current Opinion in Oncology. 4. DOI: 10.1097/00001622-199212001-00011 |
0.539 |
|
| 1991 |
Adams JM, Cory S. Transgenic models for haemopoietic malignancies. Biochimica Et Biophysica Acta. 1072: 9-31. PMID 2018781 DOI: 10.1016/0304-419X(91)90004-5 |
0.499 |
|
| 1991 |
Strasser A, Harris AW, Cory S. bcl-2 transgene inhibits T cell death and perturbs thymic self-censorship Cell. 67: 889-899. PMID 1959134 DOI: 10.1016/0092-8674(91)90362-3 |
0.366 |
|
| 1991 |
Adams JM, Cory S. Transgenic models of tumor development. Science (New York, N.Y.). 254: 1161-7. PMID 1957168 DOI: 10.1126/Science.1957168 |
0.546 |
|
| 1991 |
Strasser A, Whittingham S, Vaux DL, Bath ML, Adams JM, Cory S, Harris AW. Enforced BCL2 expression in B-lymphoid cells prolongs antibody responses and elicits autoimmune disease. Proceedings of the National Academy of Sciences of the United States of America. 88: 8661-5. PMID 1924327 DOI: 10.1073/Pnas.88.19.8661 |
0.583 |
|
| 1990 |
Strasser A, Harris AW, Bath ML, Cory S. Novel primitive lymphoid tumours induced in transgenic mice by cooperation between myc and bcl -2 Nature. 348: 331-333. PMID 2250704 DOI: 10.1038/348331A0 |
0.425 |
|
| 1990 |
Rosenbaum H, Harris AW, Bath ML, McNeall J, Webb E, Adams JM, Cory S. An E mu-v-abl transgene elicits plasmacytomas in concert with an activated myc gene. The Embo Journal. 9: 897-905. PMID 2155783 DOI: 10.1002/J.1460-2075.1990.Tb08187.X |
0.603 |
|
| 1990 |
Vaux DL, Lalor PA, Cory S, Johnson GR. In vivo expression of interleukin 5 induces an eosinophilia and expanded Ly-1B lineage populations. International Immunology. 2: 965-971. PMID 2078522 DOI: 10.1093/Intimm/2.10.965 |
0.325 |
|
| 1990 |
Strasser A, Harris AW, Vaux DL, Webb E, Bath ML, Adams JM, Cory S. Abnormalities of the immune system induced by dysregulated bcl-2 expression in transgenic mice. Current Topics in Microbiology and Immunology. 166: 175-81. PMID 2073796 DOI: 10.1007/978-3-642-75889-8_22 |
0.557 |
|
| 1990 |
Harris AW, Bath ML, Rosenbaum H, McNeall J, Adams JM, Cory S. Lymphoid tumorigenesis by v-abl and BCR-v-abl in transgenic mice. Current Topics in Microbiology and Immunology. 166: 165-73. PMID 2073795 DOI: 10.1007/978-3-642-75889-8_21 |
0.578 |
|
| 1990 |
Perkins A, Kongsuwan K, Visvader J, Adams JM, Cory S. Homeobox gene expression plus autocrine growth factor production elicits myeloid leukemia. Proceedings of the National Academy of Sciences of the United States of America. 87: 8398-402. PMID 1978323 DOI: 10.1073/Pnas.87.21.8398 |
0.543 |
|
| 1990 |
Elefanty AG, Hariharan IK, Cory S. bcr-abl, the hallmark of chronic myeloid leukaemia in man, induces multiple haemopoietic neoplasms in mice. The Embo Journal. 9: 1069-1078. DOI: 10.1002/J.1460-2075.1990.Tb08212.X |
0.365 |
|
| 1989 |
Hariharan IK, Harris AW, Crawford M, Abud H, Webb E, Cory S, Adams JM. A bcr-v-abl oncogene induces lymphomas in transgenic mice. Molecular and Cellular Biology. 9: 2798-805. PMID 2789335 DOI: 10.1128/Mcb.9.7.2798 |
0.602 |
|
| 1989 |
Rosenbaum H, Webb E, Adams JM, Cory S, Harris AW. N-myc transgene promotes B lymphoid proliferation, elicits lymphomas and reveals cross-regulation with c-myc. The Embo Journal. 8: 749-55. PMID 2785918 DOI: 10.1002/J.1460-2075.1989.Tb03435.X |
0.582 |
|
| 1989 |
Alexander WS, Adams JM, Cory S. Oncogene cooperation in lymphocyte transformation: malignant conversion of E mu-myc transgenic pre-B cells in vitro is enhanced by v-H-ras or v-raf but not v-abl. Molecular and Cellular Biology. 9: 67-73. PMID 2784537 DOI: 10.1128/mcb.9.1.67-73.1989 |
0.574 |
|
| 1989 |
Alexander WS, Bernard O, Langdon WY, Harris AW, Adams JM, Cory S. Oncogene cooperation and B-lymphoid tumorigenesis in Emu-myc transgenic mice. Haematology and Blood Transfusion. 32: 423-7. PMID 2696688 DOI: 10.1007/978-3-642-74621-5_73 |
0.604 |
|
| 1989 |
Hariharan IK, Johnson GR, Gonda TJ, Metcalf D, Adams JM, Cory S. Analysis of the leukemogenic properties of the bcr-v-abl and GM-CSF genes using a new retroviral vector. Current Topics in Microbiology and Immunology. 149: 99-107. PMID 2659286 DOI: 10.1007/978-3-642-74623-9_9 |
0.553 |
|
| 1988 |
Bowtell DDL, Cory S, Johnson GR, Gonda TJ. Comparison of expression in hemopoietic cells by retroviral vectors carrying two genes Journal of Virology. 62: 2464-2473. PMID 3373574 DOI: 10.1128/Jvi.62.7.2464-2473.1988 |
0.355 |
|
| 1988 |
Vaux DL, Cory S, Adams JM. Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells. Nature. 335: 440-2. PMID 3262202 DOI: 10.1038/335440A0 |
0.642 |
|
| 1988 |
Gerondakis S, Bernard O, Cory S, Adams JM. Immunoglobulin JH rearrangement in a T-cell line reflects fusion to the DH locus at a sequence lacking the nonamer recognition signal. Immunogenetics. 28: 255-9. PMID 2843460 DOI: 10.1007/Bf00345502 |
0.589 |
|
| 1988 |
Cory S, Adams JM. Transgenic mice and oncogenesis Annual Review of Immunology. 6: 25-48. PMID 2838049 DOI: 10.1146/Annurev.Iy.06.040188.000325 |
0.582 |
|
| 1987 |
Cory S, Harris AW, Langdon WY, Alexander WS, Corcoran LM, Palmiter RD, Pinkert CA, Brinster RL, Adams JM. The myc oncogene and lymphoid neoplasia: from translocations to transgenic mice. Haematology and Blood Transfusion. 31: 248-51. PMID 3502109 DOI: 10.1007/978-3-642-72624-8_51 |
0.606 |
|
| 1987 |
Gonda TJ, Cory S, Sobieszczuk P, Holtzman D, Adams JM. Generation of altered transcripts by retroviral insertion within the c-myb gene in two murine monocytic leukemias. Journal of Virology. 61: 2754-63. PMID 2441077 DOI: 10.1128/Jvi.61.9.2754-2763.1987 |
0.586 |
|
| 1986 |
Adams JM, Harris AW, Langdon WY, Pinkert CA, Brinster RL, Palmiter RD, Corcoran L, Alexander WS, Graham MW, Cory S. c-myc-induced lymphomagenesis in transgenic mice and the role of the Pvt-1 locus in lymphoid neoplasia. Current Topics in Microbiology and Immunology. 132: 1-8. PMID 3491731 DOI: 10.1007/978-3-642-71562-4_1 |
0.58 |
|
| 1986 |
Cory S. Activation of cellular oncogenes in hemopoietic cells by chromosome translocation. Advances in Cancer Research. 47: 189-234. PMID 3096089 DOI: 10.1016/S0065-230X(08)60200-6 |
0.325 |
|
| 1986 |
Langdon WY, Harris AW, Cory S, Adams JM. The c-myc oncogene perturbs B lymphocyte development in E-mu-myc transgenic mice. Cell. 47: 11-8. PMID 3093082 DOI: 10.1016/0092-8674(86)90361-2 |
0.602 |
|
| 1985 |
Graham M, Adams JM, Cory S. Murine T lymphomas with retroviral inserts in the chromosomal 15 locus for plasmacytoma variant translocations. Nature. 314: 740-3. PMID 3990802 DOI: 10.1038/314740A0 |
0.588 |
|
| 1985 |
Cory S, Graham M, Webb E, Corcoran L, Adams JM. Variant (6;15) translocations in murine plasmacytomas involve a chromosome 15 locus at least 72 kb from the c-myc oncogene. The Embo Journal. 4: 675-81. PMID 3924592 DOI: 10.1002/J.1460-2075.1985.Tb03682.X |
0.566 |
|
| 1985 |
Adams JM, Harris AW, Pinkert CA, Corcoran LM, Alexander WS, Cory S, Palmiter RD, Brinster RL. The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice. Nature. 318: 533-8. PMID 3906410 DOI: 10.1038/318533A0 |
0.599 |
|
| 1985 |
Corcoran LM, Cory S, Adams JM. Transposition of the immunoglobulin heavy chain enhancer to the myc oncogene in a murine plasmacytoma. Cell. 40: 71-9. PMID 2981633 DOI: 10.1016/0092-8674(85)90310-1 |
0.569 |
|
| 1985 |
Adams JM, Cory S. Myc oncogene activation in B and T lymphoid tumours Proceedings of the Royal Society of London - Biological Sciences. 226: 59-72. PMID 2866524 DOI: 10.1098/Rspb.1985.0079 |
0.586 |
|
| 1984 |
Webb E, Adams JM, Cory S. Variant (6 ; 15) translocation in a murine plasmacytoma occurs near an immunoglobulin kappa gene but far from the myc oncogene. Nature. 312: 777-9. PMID 6440031 DOI: 10.1038/312777A0 |
0.571 |
|
| 1984 |
Cory S. Immunoglobulin variable region genes. Pathology and Immunopathology Research. 3: 149-164. PMID 6438760 DOI: 10.1159/000156923 |
0.319 |
|
| 1984 |
Cory S, Gerondakis S, Corcoran LM, Bernard O, Webb E, Adams JM. Activation of the c-myc oncogene in B and T lymphoid tumors. Current Topics in Microbiology and Immunology. 113: 161-5. PMID 6332714 DOI: 10.1007/978-3-642-69860-6_27 |
0.593 |
|
| 1984 |
Corcoran LM, Adams JM, Dunn AR, Cory S. Murine T lymphomas in which the cellular myc oncogene has been activated by retroviral insertion Cell. 37: 113-122. PMID 6327047 DOI: 10.1016/0092-8674(84)90306-4 |
0.577 |
|
| 1984 |
Gerondakis S, Cory S, Adams JM. Translocation of the myc cellular oncogene to the immunoglobulin heavy chain locus in murine plasmacytomas is an imprecise reciprocal exchange. Cell. 36: 973-82. PMID 6323031 DOI: 10.1016/0092-8674(84)90047-3 |
0.557 |
|
| 1983 |
Cory S. Oncogenes and B-lymphocyte neoplasia Immunology Today. 4: 205-207. PMID 25290108 DOI: 10.1016/0167-5699(83)90024-5 |
0.331 |
|
| 1983 |
Adams JM, Gerondakis S, Webb E, Corcoran LM, Cory S. Cellular myc oncogene is altered by chromosome translocation to an immunoglobulin locus in murine plasmacytomas and is rearranged similarly in human Burkitt lymphomas. Proceedings of the National Academy of Sciences of the United States of America. 80: 1982-6. PMID 6572957 DOI: 10.1073/Pnas.80.7.1982 |
0.598 |
|
| 1983 |
Cory S, Gerondakis S, Adams JM. Interchromosomal recombination of the cellular oncogene c-myc with the immunoglobulin heavy chain locus in murine plasmacytomas is a reciprocal exchange. The Embo Journal. 2: 697-703. PMID 6416831 DOI: 10.1002/J.1460-2075.1983.Tb01487.X |
0.568 |
|
| 1983 |
Bernard O, Cory S, Gerondakis S, Webb E, Adams JM. Sequence of the murine and human cellular myc oncogenes and two modes of myc transcription resulting from chromosome translocation in B lymphoid tumours. The Embo Journal. 2: 2375-83. PMID 6321164 DOI: 10.1002/J.1460-2075.1983.Tb01749.X |
0.587 |
|
| 1983 |
Cory S, Adams JM, Gerondakis SD, Miller JF, Gamble J, Wiener F, Spira J, Francke U. Fusion of DNA region to murine immunoglobulin heavy chain locus corresponds to plasmacytoma-associated chromosome translocation. The Embo Journal. 2: 213-216. DOI: 10.1002/J.1460-2075.1983.Tb01407.X |
0.565 |
|
| 1982 |
Adams JM, Gerondakis S, Webb E, Mitchell J, Bernard O, Cory S. Transcriptionally active DNA region that rearranges frequently in murine lymphoid tumors. Proceedings of the National Academy of Sciences of the United States of America. 79: 6966-70. PMID 6294668 DOI: 10.1073/Pnas.79.22.6966 |
0.583 |
|
| 1981 |
Adams JM, Kemp DJ, Bernard O, Gough N, Webb E, Tyler B, Gerondakis S, Cory S. Organization and expression of murine immunoglobulin genes. Immunological Reviews. 59: 5-32. PMID 6273295 DOI: 10.1111/J.1600-065X.1981.Tb00454.X |
0.525 |
|
| 1981 |
Cory S, Webb E, Gough J, Adams JM. Recombination events near the immunoglobulin Cmu gene join variable and constant region genes, switch heavy-chain expression, or inactivate the locus. Biochemistry. 20: 2662-71. PMID 6263315 DOI: 10.1021/Bi00512A047 |
0.561 |
|
| 1980 |
Cory S, Adams JM, Kemp DJ. Somatic rearrangements forming active immunoglobulin mu genes in B and T lymphoid cell lines. Proceedings of the National Academy of Sciences of the United States of America. 77: 4943-7. PMID 6776532 DOI: 10.1073/Pnas.77.8.4943 |
0.617 |
|
| 1980 |
Cory S, Jackson J, Adams JM. Deletions in the constant region locus can account for switches in immunoglobulin heavy chain expression. Nature. 285: 450-6. PMID 6772957 DOI: 10.1038/285450A0 |
0.548 |
|
| 1980 |
Kemp DJ, Harris AW, Cory S, Adams JM. Expression of the immunoglobulin C mu gene in mouse T and B lymphoid and myeloid cell lines. Proceedings of the National Academy of Sciences of the United States of America. 77: 2876-80. PMID 6771761 DOI: 10.1073/Pnas.77.5.2876 |
0.596 |
|
| 1980 |
Gough NM, Kemp DJ, Tyler BM, Adams JM, Cory S. Intervening sequences divide the gene for the constant region of mouse immunoglobulin mu chains into segments, each encoding a domain. Proceedings of the National Academy of Sciences of the United States of America. 77: 554-8. PMID 6767239 DOI: 10.1073/Pnas.77.1.554 |
0.579 |
|
| 1980 |
Cory S, Adams JM. Deletions are associated with somatic rearrangement of immunoglobulin heavy chain genes Cell. 19: 37-51. PMID 6766810 DOI: 10.1016/0092-8674(80)90386-4 |
0.584 |
|
| 1980 |
Adams JM, Webb E, Gerondakis S, Cory S. Cloned embryonic DNA sequences flanking the mouse immunoglobulin C gamma 3 and C gamma 1 genes. Nucleic Acids Research. 8: 6019-32. PMID 6258159 DOI: 10.1093/Nar/8.24.6019 |
0.567 |
|
| 1980 |
Adams JM, Gough NM, Webb EA, Tyler BM, Jackson J, Cory S. Molecular cloning of mouse immunoglobulin heavy chain messenger ribonucleic acids coding for mu, alpha, gamma 1, gamma 2a, and gamma 3 chains. Biochemistry. 19: 2711-9. PMID 6249338 DOI: 10.1021/Bi00553A027 |
0.503 |
|
| 1980 |
Gough NM, Webb EA, Cory S, Adams JM. Molecular cloning of seven mouse immunoglobulin kappa chain messenger ribonucleic acids. Biochemistry. 19: 2702-10. PMID 6249337 DOI: 10.1021/Bi00553A026 |
0.519 |
|
| 1979 |
Kemp DJ, Cory S, Adams JM. Cloned pairs of variable region genes for immunoglobulin heavy chains isolated from a clone library of the entire mouse genome. Proceedings of the National Academy of Sciences of the United States of America. 76: 4627-31. PMID 116236 DOI: 10.1073/Pnas.76.9.4627 |
0.561 |
|
| 1979 |
Gough NM, Cory S, Adams JM. Identical 3' non-coding sequences in five mouse Ig kappa chain mRNAs favour a unique C kappa gene. Nature. 281: 394-6. PMID 113684 DOI: 10.1038/281394A0 |
0.546 |
|
| 1977 |
Cory S, Adams JM. A very large repeating unit of mouse DNA containing the 18S, 28S and 5.8S rRNA genes Cell. 11: 795-805. PMID 560915 DOI: 10.1016/0092-8674(77)90292-6 |
0.542 |
|
| 1977 |
Bernard OD, Jackson J, Cory S, Adams JM. Noncoding nucleotide sequence in the 3'-terminal region of a mouse immunoglobulin kappa chain messenger RNA determined by analysis of complementary DNA. Biochemistry. 16: 4117-25. PMID 410436 DOI: 10.1021/Bi00637A027 |
0.539 |
|
| 1977 |
Schmeckpeper BJ, Cory S, Adams JM. Comparison of immunoglobulin chains made in ascites extract and reticulocyte lysate programmed with mRNA from four mouse myelomas. Biochimica Et Biophysica Acta. 476: 303-20. PMID 406925 DOI: 10.1016/0005-2787(77)90295-7 |
0.529 |
|
| 1977 |
Bernard O, Cory S, Adams JM. Synthesis of complementary RNA on RNA templates using the DNA-dependent RNA polymerase of Escherichia coli. Biochimica Et Biophysica Acta. 478: 407-16. PMID 334264 DOI: 10.1016/0005-2787(77)90096-X |
0.519 |
|
| 1976 |
Cory S, Genin C, Adams JM. Modified nucleosides and 5'-end groups in purified mouse immunoglobulin light chain mRNA and rabbit globin mRNA detected by borohydride labelling. Biochimica Et Biophysica Acta. 454: 248-62. PMID 826277 DOI: 10.1016/0005-2787(76)90228-8 |
0.509 |
|
| 1975 |
Adams JM, Cory S. Modified nucleosides and bizarre 5′-termini in mouse myeloma mRNA Nature. 255: 28-33. PMID 1128665 DOI: 10.1038/255028A0 |
0.527 |
|
| 1975 |
Cory S, Adams JM. The modified 5' terminal sequences in messenger RNA of mouse myeloma cells Journal of Molecular Biology. 99: 519-547. PMID 175165 DOI: 10.1016/S0022-2836(75)80170-7 |
0.516 |
|
| 1974 |
Schmeckpeper BJ, Cory S, Adams JM. Translation of immunoglobulin mRNAs in a wheat germ cell-free system. Molecular Biology Reports. 1: 355-63. PMID 4473705 DOI: 10.1007/Bf00309570 |
0.515 |
|
| 1972 |
Cory S, Adams JM, Spahr PF, Rensing U. Sequence of 51 nucleotides at the 3'-end of R17 bacteriophage RNA. Journal of Molecular Biology. 63: 41-56. PMID 5016970 DOI: 10.1016/0022-2836(72)90520-7 |
0.519 |
|
| 1972 |
Adams JM, Cory S, Spahr PF. Nucleotide sequences of fragments of R17 bacteriophage RNA from the region immediately preceding the coat-protein cistron. European Journal of Biochemistry. 29: 469-79. PMID 4563341 DOI: 10.1111/J.1432-1033.1972.Tb02011.X |
0.531 |
|
| 1972 |
Adams JM, Spahr PF, Cory S. Nucleotide sequence from the 5' end to the first cistron of R17 bacteriophage ribonucleic acid. Biochemistry. 11: 976-88. PMID 4335292 DOI: 10.1021/Bi00756A006 |
0.492 |
|
| 1970 |
Adams JM, Cory S. Untranslated nucleotide sequence at the 5'-end of R 17 bacteriophage RNA Nature. 227: 570-574. PMID 5429288 DOI: 10.1038/227570A0 |
0.514 |
|
| 1970 |
Cory S, Spahr PF, Adams JM. Untranslated Nucleotide Sequences in R17 Bacteriophage RNA Cold Spring Harbor Symposia On Quantitative Biology. 35: 1-12. DOI: 10.1101/Sqb.1970.035.01.005 |
0.499 |
|
| Show low-probability matches. |